article thumbnail

Green Practice News: April 2025

My Green Doctor

In This Issue : New Research: Teaching Patients about Climate Resilience Make the Pledge Today to Go Green Get Ready for Earth Day 2025 (part 2)! It tells your office colleagues and patients that your healthcare practice or clinic is committed to forging a healthier work space and community. The healthcare sector contributes 8.5%

article thumbnail

Be The Market: How Doctors Should Invest Their Money

The Motivated MD

With increasing emphasis on patient turnover and documentation, all while navigating the complexities of billing and authorization, our jobs are stressful and time-consuming. How, then, can any physician find the time to research individual companies and make educated decisions on which publicly traded businesses are undervalued?

Finance 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Public Facing Education via Social Media: A Podcast with Julie McFadden, Matt Tyler, Sammy Winemaker and Hsien Seow

GeriPal

all of whom focus their efforts on educating the general public about living and dying with a serious illness. Advice for others who might want to dabble in social media outreach So, take a listen and check out their social media sites to get inspired. He was also the one who we have to thank for suggesting this podcast!

Education 127
article thumbnail

8 Reasons Why Family Physicians are the Actual Stars of Medicine

Family Medicine Initiative

Having Your Own Long-Term GP Can Save Your Life Patients who choose a GP rather than a specialist as their primary care provider have a 19% 8 lower mortality and produce 22% 9 -33% 8 lower healthcare spending. 11 , 13 Over time, GPs come to know their patients well. Over time, GPs put their patients into context.

article thumbnail

STATEMENT RELEASE: Doctors for America’s FDA Task Force Dismayed by Kennedy Testimony

Doctors for America

during yesterday’s Senate Health, Education, Labor and Pensions (HELP) Committee hearing. As a result of these massive cuts to FDA’s scientific and technical expertise, drug development and approvals have slowed down, hindering access for patients to promising treatments. Kennedy Jr.